GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+8.04%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.26B
AUM Growth
+$69.7M
(+5.9%)
Cap. Flow
+$20.2M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520
Top Buys
| 1 |
Monster Beverage
MNST
|
+$3.51M |
| 2 |
UGI
UGI
|
+$3.32M |
| 3 |
APA Corp
APA
|
+$3.31M |
| 4 |
Zoetis
ZTS
|
+$3.2M |
| 5 |
Lemonade
LMND
|
+$3.1M |
Top Sells
| 1 |
CRH
CRH
|
+$5.34M |
| 2 |
Aon
AON
|
+$4.58M |
| 3 |
Zillow
ZG
|
+$4.44M |
| 4 |
Kura Sushi USA
KRUS
|
+$4.13M |
| 5 |
Sprott Uranium Miners ETF
URNM
|
+$4.08M |
Sector Composition
| 1 | Technology | 16.16% |
| 2 | Financials | 12.35% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Healthcare | 11.74% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Abeona Therapeutics
ABEO
$335M
| $178K | 0.01% |
+24,561
| New | +$178K |
|
|
IGMS
1427
DELISTED
IGM Biosciences
IGMS
| $178K | 0.01% |
+18,398
| New | +$178K |
|
1428
DocGo
DCGO
$148M
| $176K | 0.01% |
+43,512
| New | +$176K |
|
|
NKLA
1429
DELISTED
Nikola Corporation Common Stock
NKLA
| $176K | 0.01% |
+5,627
| New | +$176K |
|
1430
Codexis
CDXS
$219M
| $173K | 0.01% |
49,630
-787,406
| -94% | -$2.74M |
|
1431
OneSpaWorld
OSW
$2.24B
| $171K | 0.01% |
+12,950
| New | +$171K |
|
|
KLRS
1432
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $171K | 0.01% |
9,853
+776
| +9% | +$13.5K |
|
1433
Star Group
SGU
$389M
| $168K | 0.01% |
+16,757
| New | +$168K |
|
1434
Zentalis Pharmaceuticals
ZNTL
$105M
| $167K | 0.01% |
+10,602
| New | +$167K |
|
1435
Farmers National Banc Corp
FMNB
$562M
| $163K | 0.01% |
+12,231
| New | +$163K |
|
1436
BRF SA
BRFS
$5.99B
| $162K | 0.01% |
+49,844
| New | +$162K |
|
|
EARN
1437
Ellington Residential Mortgage REIT
EARN
$213M
| $161K | 0.01% |
23,304
-24,803
| -52% | -$171K |
|
1438
Dynavax Technologies
DVAX
$1.14B
| $158K | 0.01% |
+12,725
| New | +$158K |
|
1439
Mersana Therapeutics
MRSN
$36.7M
| $158K | 0.01% |
+1,410
| New | +$158K |
|
1440
Alto Ingredients
ALTO
$89M
| $156K | 0.01% |
+71,454
| New | +$156K |
|
1441
Amcor
AMCR
$19B
| $156K | 0.01% |
+16,416
| New | +$156K |
|
|
CNTA
1442
Centessa Pharmaceuticals
CNTA
$3.04B
| $154K | 0.01% |
+13,587
| New | +$154K |
|
1443
Valens Semiconductor
VLN
$196M
| $154K | 0.01% |
65,692
+24,807
| +61% | +$58.2K |
|
1444
Ultralife
ULBI
$112M
| $153K | 0.01% |
+17,337
| New | +$153K |
|
1445
Arcos Dorados Holdings
ARCO
$1.47B
| $152K | 0.01% |
+13,672
| New | +$152K |
|
1446
Phathom Pharmaceuticals
PHAT
$874M
| $151K | 0.01% |
+14,174
| New | +$151K |
|
|
VZIO
1447
DELISTED
VIZIO Holding Corp.
VZIO
| $151K | 0.01% |
13,777
+3,416
| +33% | +$37.4K |
|
1448
Patterson-UTI
PTEN
$2.11B
| $148K | 0.01% |
12,398
-14,516
| -54% | -$173K |
|
|
ITI
1449
DELISTED
Iteris, Inc.
ITI
| $148K | 0.01% |
+29,961
| New | +$148K |
|
1450
Foghorn Therapeutics
FHTX
$291M
| $147K | 0.01% |
21,855
-19,440
| -47% | -$131K |
|